Diabetologia · 2015 · 22 citations · 29 references
MedicineEndocrinologySurgeryHealth EquityHuman NutritionTransplant SurgeryDiabetes ManagementDiabetes MellitusPancreas TransplantationTransplant OutcomesGlucose MonitoringMetabolic Complication MonitoringMetabolic Complications After TransplantationMetabolic Complications ManagementMixed-meal Tolerance TestingPancreatic Islet Cell TransplantationPost-transplant HyperglycemiaSocioeconomic Composition
AIMS/HYPOTHESIS: Type 1 diabetes complicated by hypoglycaemia is prevalent in socioeconomically deprived populations. Islet transplantation is of proven efficacy in type 1 diabetes complicated by hypoglycaemia, but it is not known if nationally funded programmes reach the socioeconomically deprived. Our aim was to determine: (1) socioeconomic indices in participants referred to our nationally funded programme; and (2) if metabolic outcomes in our transplant recipients were improved. METHODS: Participants referred (n = 106) and receiving transplants (n = 18; 32 infusions) were examined with respect to socioeconomic status (deprivation category score) and their ability to work and drive. In participants followed for ≥12 months after transplantation, metabolic and anthropometric measurements (n = 14) were recorded pre- and post-transplant (assessed ~1, ~3, ~6 and ~12 months with mixed-meal tolerance tests and 6 day continuous glucose monitoring assessments). Donor data was also examined. RESULTS: There was a greater prevalence of socioeconomic deprivation in referred and transplant recipients than the general population (p < 0.05). Of the transplant recipients, 73% were socioeconomically deprived, 88% did not hold a driver's license and 94% had reduced ability to work (all p < 0.01 vs referred participants). Donors were predominantly obese and included circulatory death donors. At 12 months, 93% of participants who had received transplants had graft function, diminished frequency of hypoglycaemia (10 [4-11] vs 0 [0-2] hypoglycaemic episodes/week), improved awareness of hypoglycaemia (Gold score 7 [5-7] vs 1 [1-2]) and glycaemic control (HbA1c: 7.9% [7.2-8.5%]; 63 [55-69] mmol/mol vs 7.2% [6.8-7.5%]; 55 [51-58] mmol/mol), diminished glycaemic lability and decreased central adiposity (all p < 0.05). CONCLUSIONS/INTERPRETATION: A nationally funded islet transplant programme reaches the socioeconomically deprived and outcomes are significantly improved in this group.
29
Five-Year Follow-Up After Clinical Islet Transplantation
Edmond A. Ryan, Breay W. Paty, Peter Senior et al. · Diabetes · 2005 · 1.6K citations · Full text
Medicine, Endocrinology, Surgery +14
Successful Islet Transplantation
Edmond A. Ryan, Jonathan R.T. Lakey, Breay W. Paty et al. · Diabetes · 2002 · 726 citations · Full text
Medicine, Endocrinology, Surgery +16
Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010
Franca B. Barton, Michael R. Rickels, Rodolfo Alejandro et al. · Diabetes Care · 2012 · 722 citations · Full text
Medicine, Endocrinology, Surgery +17